Race-Specific Propofol Titration to Effect for Procedural Sedation
- Conditions
- UnconsciousnessSedative OverdoseHypoxemiaApnea, Postanesthetic
- Interventions
- Procedure: Titrate propofol monotherapy infusion to effect
- Registration Number
- NCT03290859
- Lead Sponsor
- University of Florida
- Brief Summary
Prospectively evaluate newly established guidelines and make clinicians aware of inter-racial difference in propofol sensitivity.
- Detailed Description
The primary motivation in conducting this study is to conduct the implementation science, i.e., formalize and train, and retrain if needed, anesthesia providers in the standard practice of titrating infusion rate to effect and clinically evaluate the effect of race and ethnicity on propofol monotherapy sedation during GI endoscopy. The ultimate goal is to make it less likely that patients from races known to be sensitive to propofol experience inadvertent overdosing.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 2780
- Patients undergoing propofol sedation at Gainesville (GNV) and Jacksonville (JAX) GI Endoscopy suites
- Age range 18 - 80 years old
- Patients whose race can be identified from the electronic patient information chart (EPIC)
- Patients who identify as multiracial in Epic
- Patients who identify as Other in Epic
- Patients who refuse to indicate their race in Epic
- Patients whose race is listed as unknown in Epic
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Training intervention Titrate propofol monotherapy infusion to effect Train anesthesia providers who deliver propofol sedation for GI endoscopy procedures to follow a uniform propofol monotherapy administration guideline to titrate propofol monotherapy infusion to effect according to a standardized protocol.
- Primary Outcome Measures
Name Time Method Change in the recovery times among races and ethnicities Change from baseline up to 24 hours Monitored using aggregate data for metrics of recovery times
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
UF Health
🇺🇸Gainesville, Florida, United States